Evidence map›Paper›PMID 25029025›Full record

ReviewNature reviews. Microbiology2014

Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Oliver T Fackler, Thomas T Murooka, Andrea Imle, Thorsten R Mempel

Abstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oliver T Fackler1] Department of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany. [2] German Center for Infection Research, Heidelberg University, 69120 Heidelberg, Germany.
Thomas T Murooka1] The Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA.
Andrea ImleDepartment of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Thorsten R Mempel1] The Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [2] Harvard Medical School, Boston, Massachusetts 02115, USA.

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
Migratory Properties of HIV-infected T cells in vivoR01AI097052 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MEMPEL, THORSTEN ROMAN · 2013 to 2016
$2.5M
Novel Strategies to Antagonize Cocaine-Enhanced HIV PathobiologyR01DA036298 · NIDA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GROOPMAN, JEROME E, MEMPEL, THORSTEN ROMAN · 2013 to 2017
$2.0M
Migratory Properties of HIV-infected T Cells in VivoR56AI097052 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MEMPEL, THORSTEN ROMAN · 2011 to 2011
$601k
NIAID NIH HHS 5P30AI060354-09NIAID NIH HHS P01 AI0178897NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI097052NIAID NIH HHS R56 AI097052NIAID NIH HHS T32 AI007387NIAID NIH HHS U19 AI082630NIDA NIH HHS R01 DA036298
6 · The paper itself

Abstract

In vitro studies in primary or immortalized cells continue to be used to elucidate the essential principles that govern the interactions between HIV-1 and isolated target cells. However, until recently, substantial technical barriers prevented this information from being efficiently translated to the more complex scenario of HIV-1 spread in the host in vivo, which has limited our understanding of the impact of host physiological parameters on the spread of HIV-1. In this Review, we discuss the recent development of imaging approaches to visualize HIV-1 spread and the adaptation of these approaches to organotypic ex vivo models and animal models. We focus on new concepts, including the mechanisms and in vivo relevance of cell-cell transmission for HIV-1 spread and the function of the HIV-1 pathogenesis factor Nef, which have emerged from the application of these integrative approaches in complex cell systems.

Indexed as

Models, BiologicalAnimalsDisease Models, AnimalHIV-1HIV InfectionsHumans

Identifiers

PMID25029025
PMCPMC5687059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.